Prof. Reiter is the former dean of the Faculty of Biology and the head of the Laboratory of Molecular Immunology at the Technion, Israel Institute of Technology. Prof. Reiter is a world leader in the isolation of human T-cell receptor-like (TCRL) molecules, with various applications in molecular immunology of cancer and infectious diseases. His work involves the development of novel immunotherapeutic approaches, as well as the study of molecular mechanisms in anti-tumor and anti-viral immunity. Prof. Reiter received his Ph.D. from the Department of Immunology at the Weizmann Institute of Science and subsequently spent five years at the National Cancer Institute (NCI) at the Laboratory of Molecular Biology headed by Dr. Ira Pastan, where he developed new approaches in antibody engineering. Prof. Reiter published over 100 scientific papers and reviews and holds 15 patents. He is the co-founder and CTO of Applied Immune Technology (AIT) Inc. and serves as an advisor to several pharmaceutical and biotechnology companies.
Faculty:Biology
